Breast Cancer Market Report: 2011 Edition

Breast cancer is one of the most common types of cancer after lung cancer and the second leading cause of death in women. Globally, more than one million women are diagnosed with breast cancer annually. Breast cancer is mainly found in women compared to men. Though women of all ages are at risk of developing breast cancer, older woman have greater chances of developing it. The incidence rates of breast cancer vary noticeably; registering the highest rate in the US followed by Europe and the lowest rate in Africa and Asia.

Breast cancer usually affects women over the age of 40 and above. In the past few years, the cases of breast cancer have increased tremendously in western countries like the US and Europe. The breast cancer market is comprised of three segments: screening, diagnostic and treatment. The breast cancer market is driven by various factors like aging population in women, obesity, hormonal factors and family history amongst others.

The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancement in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.

The stages of breast cancer are of critical importance and they alone determine the treatment method and the extent to which it can be cured. Mammography is believed to diagnose 85-90% of breast cancers in women over 50, and is capable of identifying a lesion one to four years before a lump can be felt. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by drugs and radiation therapy or both.

This report provides an overview of breast cancer, its types and stages, and incidence rates. The markets for screening, diagnosis and treatment of breast cancer, including mammography, biopsy, chemotherapy, radiotherapy and drugs, have been analyzed. It also analyzes the drivers, issues and trends in the breast care market. The major players in the market are profiled along with their financials and key business strategies. SHOW LESS READ MORE >

1. Breast Cancer Market Overview
1.1 Introduction
Types of Breast Cancer
Stages of Breast Cancer
Major Causes

1.2 Global Breast Cancer Market
New Cases Worldwide
Developed Vs Developing Countries

1.3 The US Breast Cancer Market
Incidence Rates
Death Rates
Other Statistics

2. Breast Cancer Screening & Diagnosis Market
2.1 Introduction
2.2 Breast Cancer Screening Market
2.2.1 Mammography Market
2.2.2 Oncotype DX Breast Cancer Test Market
2.2.3 Biopsy Market

3. Breast Cancer Treatment Market
3.1 Therapy Market
3.1.1 Radiotherapy Market
3.2 Breast Cancer Drug Market

4. Metastatic Breast Cancer Market
Breakdown by Geography
United States
Europe

5. Breast Cancer - Market Dynamics
5.1 Growth Drivers
5.1.1 Aging Population of Women
5.1.2 Genetic Tendency & Family History of Breast Cancer
5.1.3 Hormonal Factors
5.1.4 High Breast Tissue Density
5.1.5 Obesity

5.2 Key Issues
5.2.1 Imaging Radiation Increases Breast Cancer Risk
5.2.2 Lesser Availability of Health Insurers in Breast Cancer

5.3 Market Trends
5.3.1 Advancements in Imaging Technology
5.3.2 Paradigm Shift to Less Invasive Procedures

6. Company Profiles
6.1 Hologic
Overview
Key Financials
Business Strategies
Strategic acquisitions
New Product Development

6.2 Bard Biopsy Systems (SenoRx Inc)
Overview
Key Financials
Business Strategies
Research & Development

6.3 Johnson and Johnson
Overview
Key Financials
Business Strategies
New Product Development
Strategic Acquisitions

List of Charts:

Types of Breast Cancer
New Cancer Cases Registered Globally During 2009
Breast Cancer New Cases Worldwide (2004-2009)
The US Breast Cancer Incidence Share Among all Cancer Types (2009)
New Breast Cancer Cases and Death Rate in the US (2004-2009)
New In Situ & Invasive Breast Cancer Cases and Death Rate in the US (2010)
Breast Cancer Screening, Diagnosis and Treatment Techniques
The US Screening Market by Value (2010-2012F)
Market Share of Regions in Mammography Equipment Market (2009)
Number of Mammographies performed in the US (2009)
Market Share in Mammography Equipment Installed Base (2009)
Breast Biopsy Market Share Worldwide (2009)
The US Breast Biopsy Market by Value (2008/2010)
Various Biopsy Methods
Global Breast Cancer Treatment Market by Value (2010)
The US Breast Cancer Therapy Market by Value (2009/2011F)
Radiation Therapy Market Share Worldwide (2009)
Global Breast Cancer Drugs Market by Value (2009/2011F)
Metastatic Breast Cancer Market Revenues by Geography (2009-2015F)
Worldwide Aging Population of Women 65+ (2005-2013F)
Age-specific Probabilities of Developing Breast Cancer (2009)
Hologic INC Total Revenues (2006-2010)
Bard Biopsy Systems (SenoRx Inc) Total Revenues (2008-2010)
Johnson & Johnson Total Revenues (2006-2010)
Medical Devices and Diagnostics Segment Revenues (2010)
Consumer Segment Revenues (2010)

List of Tables:

Stages of Breast Cancer
Survival Rates at Different Stages of Breast Cancer
Causes and Relative Risks of Breast Cancer
Number of Cases in Developed and Developing Countries (2007-2009)
Incidence and Mortality Rate (%) Before the Age of 65 Years (2009)
Age-Specific Probabilities of Developing Breast Cancer (2009)
Breast Cancer Incidence Rates in Different Races in the US (2009)
Breast Cancer Death Rates in Different Races in the US (2009)
Survival (%) Rate by Stage at Diagnosis in Breast Cancer
Five Year Relative Survival Rate at Different Stages
Relative Survival Rate in Years for Women after Getting Diagnosed
Types of Breast Cancer Diagnosis at Different Age-groups
Effectiveness of Breast Cancer Screening Methods
The US Mammography Model (2006-2010F)
The US Oncotype DX Test Model (2009-2012F)
Several Ways of Breast Cancer Treatment
Therapies Used at Different Stages
The US MBC Market Outlook (2009-2015E)
Europe MBC Market Outlook (2009-2015E)
Hologic INC Total Revenues by Segments (2009/2010)

- Hologic

- Bard Biopsy Systems (SenoRx Inc)

- Johnson and Johnson